Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 7/20 | 0.55 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | STAT6 | P42226 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17147746 | 1.00 | PKM (0.55) | PKMNLRP3ALDH1A1LMNATP53 | |
| SCHEMBL18334098 | 0.83 | PKM (0.51) | PKMNLRP3ALDH1A1LMNATP53 | |
| SCHEMBL29368384 | 0.82 | PKM (0.44) | PKMNLRP3ALDH1A1LMNATP53 | |
| SCHEMBL30463131 | 0.79 | PKM (0.47) | PKMNLRP3ALDH1A1LMNATP53 | |
| SCHEMBL21527011 | 0.77 | PKM (0.48) | PKMNLRP3ALDH1A1LMNATP53 | |
| SCHEMBL17147744 | 0.77 | PKM (0.46) | PKMNLRP3ALDH1A1LMNATP53 | |
| SCHEMBL18334095 | 0.77 | PKM (0.46) | PKMNLRP3ALDH1A1LMNATP53 | |
| SCHEMBL29756635 | 0.75 | CYP19A1 (0.53) | PKMNLRP3ALDH1A1LMNATP53 | |
| SCHEMBL26313818 | 0.73 | PKM (0.42) | PKMNLRP3ALDH1A1LMNATP53 | |
| Reynosin SCHEMBL1683362 | 0.72 | PKM (0.51) | PKMNLRP3ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10463644-B2 | Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation | ACCENDATECH (CN) | 2019-11-05 | — | — | US | disclosed |
| US-20160367525-A1 | USES OF SESQUITERPENE LACTONE COMPOUNDS AND THEIR DERIVATIVES IN DRUGS PREPARATION | ACCENDATECH (CN) | 2016-12-22 | — | — | US | disclosed |
| US-20160367525-A1 | USES OF SESQUITERPENE LACTONE COMPOUNDS AND THEIR DERIVATIVES IN DRUGS PREPARATION | ACCENDATECH (CN) | 2016-12-22 | — | — | US | disclosed |
| US-20150336919-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | CHO DANG PHARM. CO., LTD. (KR) | 2015-11-26 | — | — | US | disclosed |
| US-20150336919-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | CHO DANG PHARM. CO., LTD. (KR) | 2015-11-26 | — | — | US | disclosed |
| US-20150299155-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | CHO DANG PHARM. CO., LTD. | 2015-10-22 | — | — | US | disclosed |
| US-20150299155-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | CHO DANG PHARM. CO., LTD. | 2015-10-22 | — | — | US | disclosed |
| US-20150284353-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | CHO DANG PHARM, CO., LTD. a corporation | 2015-10-08 | — | — | US | disclosed |
| US-20150284353-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | CHO DANG PHARM, CO., LTD. a corporation | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10463644-B2 | Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation | MCL1, TNF, LSS | PKM 3846/4885NLRP3 745/4885ALDH1A1 70/4885 |
| US-20150336919-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | SI, VIP, PGC | PKM 2651/4885NLRP3 343/4885ALDH1A1 2076/4885 |
| US-20150284353-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | SI, VIP, GGPS1 | PKM 2717/4885NLRP3 320/4885ALDH1A1 2157/4885 |
| US-20160367525-A1 | USES OF SESQUITERPENE LACTONE COMPOUNDS AND THEIR DERIVATIVES IN DRUGS PREPARATION | MCL1, TNF, LSS | PKM 3846/4885NLRP3 745/4885ALDH1A1 70/4885 |
| US-20150299155-A1 | Sesquiterpene lactone-based pharmaceutical composition for treating gastrointestinal diseases | SI, VIP, PGC | PKM 2651/4885NLRP3 343/4885ALDH1A1 2076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.